News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Suzhou Alphamab To Start China Trial Of Biologic Infertility Treatment



11/4/2016 9:58:04 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
Suzhou Alphamab will start a China Phase I trial for KN015, a biologic treatment for infertility. It is the first of Alphamab's novel biologic/biosimilar programs to reach the clinic. KN015 is a long-acting human follicle-stimulating hormone (FSH), used as part of an assisted reproductive therapy to develop multiple follicles in women. Unlike other currently available programs, KN015 is expected to require only a single injection, rather than daily injections, because of its enhanced half-life.

Read at ChinaBio Today


comments powered by Disqus
Alphamab
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES